Flushing: Difference between revisions
(→Causes) |
Kiran Singh (talk | contribs) |
||
(15 intermediate revisions by 6 users not shown) | |||
Line 29: | Line 29: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"|[[Acetylcysteine]], [[Acipimox]], [[Adenosine]], [[Ambrisentan]], [[Amlodipine]], [[Amlodipine and Benazepril]], [[Amyl nitrite]], [[Aspirin]], [[Atropine]], [[Aztreonam]], [[Betahistine]], [[Bethanechol chloride]], [[Bosentan]], [[Bromocriptine]], [[Butyl nitrite]], [[Cabergoline]], [[Calcitonin]], [[Calcium channel blockers]], [[Caspofungin]], [[Chlorpropamide]], [[Cholinergics]], [[Cyclosporin]], [[Cyclosporine]], [[Cyproterone acetate]], [[caspofungin acetate]] [[Danazol]], [[Desmopressin]], [[Dinoprostone]], [[Disulfiram]], [[Eletriptan]], [[Epoprostenol]], [[Erythropoietin]], [[Ethanol]], [[Felodipine]], [[Fenoldopam]], [[Gemeprost]], [[Gestrinone]], [[Glatiramer acetate]], [[Glyceryl trinitrate]], [[Granulocyte-macrophage colony stimulating factor]], [[Isosorbide dinitrate]], [[Isosorbide mononitrate]], [[Isradipine]], [[Licorice]], [[Lysuride]], [[Methionine]], [[Metrifonate]], [[Micafungin]], [[Morphine]], [[Nabilone]], [[Nasal decongestants]], [[Nicorandil]], [[Nicotinic acid]], [[Nifedipine]], [[Nitrendipine]], [[Nitroglycerin]], [[Opioids]], [[Oxcarbazepine]], [[Pergolide]], [[Physiological response to vasodilators ]], [[Piribedil]], [[Probenecid]], [[Prostaglandins]], [[Protamine sulfate]], [[Psychedelics]], [[Quinidine]],[[Reboxetine]], [[Regadenoson]], [[Reproterol]], [[Retinoids]], [[Rifampin]], [[Ropinirole]], [[Salbutamol]], [[Secretin human]], [[Serotonin]], [[Sildenafil]], [[Sodium nitrite]], [[Sorafenib]], [[Sulprostone]], [[Tadalafil]], [[Tamoxifen]], [[Thyrotropin releasing hormone]], [[Thyrotrophin releasing peptide]], [[Tretinoin]], [[Triamcinolone]], [[Trilostane]], [[Vancomycin]], [[Vardenafil]], [[Vortioxetine]] | |bgcolor="Beige"|[[Acetylcysteine]], [[Acipimox]], [[Adenosine]], [[Agalsidase beta]], [[Ambrisentan]], [[Amlodipine]], [[Amlodipine and Benazepril]], [[Amyl nitrite]], [[Aspirin]], [[Atropine]], [[Aztreonam]], [[Betahistine]], [[Bethanechol chloride]], [[Bosentan]], [[Bromocriptine]], [[Butyl nitrite]], [[Cabergoline]], [[Calcitonin]], [[Calcium channel blockers]], [[Caspofungin]], [[Chlorpropamide]], [[Cholinergics]], [[Corticorelin]], [[Cyclosporin]], [[Cyclosporine]], [[Cyproterone acetate]], [[caspofungin acetate]] [[Danazol]], [[Desmopressin]], [[Dinoprostone]], [[Disulfiram]], [[Eletriptan]], [[Epirubicin ]], [[Epoprostenol]], [[Erythropoietin]], [[Ethanol]], [[Felodipine]], [[Fenoldopam]], [[Flutemetamol F 18]], [[Flurazepam hydrochloride]], [[Gemeprost]], [[Gestrinone]], [[Glatiramer acetate]], [[Glucarpidase]], [[Glyceryl trinitrate]], [[Granulocyte-macrophage colony stimulating factor]], [[Homatropine]], [[Isosorbide dinitrate]], [[Isosorbide mononitrate]], [[Isoproterenol (aerosol)]], [[Isradipine]], [[Licorice]], [[Lysuride]], [[Metaproterenol]], [[Methionine]], [[Metrifonate]], [[Micafungin]], [[Mivacurium chloride]], [[Morphine]], [[Nabilone]], [[Nasal decongestants]], [[Niacin]], [[Nicorandil]], [[Nicotinic acid]], [[Nifedipine]], [[Nitrendipine]], [[Nitroglycerin]], [[Opioids]], [[Oxcarbazepine]], [[Pergolide]], [[Physiological response to vasodilators ]], [[Piribedil]], [[Polymyxin B]], [[Probenecid]], [[Prostaglandins]], [[Protamine sulfate]], [[Protirelin]], [[Psychedelics]], [[Quinidine]], [[Ramucirumab]], [[Reboxetine]], [[Regadenoson]], [[Reproterol]], [[Retinoids]], [[Rifampin]], [[Ropinirole]], [[Salbutamol]], [[Secretin human]], [[Serotonin]], [[Sildenafil]], [[Sodium nitrite]], [[Sorafenib]], [[Sulprostone]], [[Tadalafil]], [[Tamoxifen]], [[Teniposide]], [[Thyrotropin releasing hormone]], [[Thyrotrophin releasing peptide]], [[Tretinoin]], [[Triamcinolone]], [[Trilostane]], [[Vancomycin]], [[Vardenafil]], [[Vortioxetine]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 213: | Line 213: | ||
*[[Nasal decongestants]] | *[[Nasal decongestants]] | ||
*[[Neuroendocrine tumors]] | *[[Neuroendocrine tumors]] | ||
*[[Niacin]] | |||
*[[Nicorandil]] | *[[Nicorandil]] | ||
*[[Nicotinic acid]] | *[[Nicotinic acid]] | ||
Line 235: | Line 237: | ||
*[[Quincke's edema]] | *[[Quincke's edema]] | ||
*[[Quinidine]] | *[[Quinidine]] | ||
*[[Ramucirumab]] | |||
*[[Rapid changes in temperature]] | *[[Rapid changes in temperature]] | ||
*[[Reboxetine]] | *[[Reboxetine]] | ||
Line 260: | Line 263: | ||
*[[Tadalafil]] | *[[Tadalafil]] | ||
*[[Tamoxifen]] | *[[Tamoxifen]] | ||
*[[Teniposide]] | |||
*[[Thrombocytosis]] | *[[Thrombocytosis]] | ||
*[[Thyrotropin releasing hormone]] | *[[Thyrotropin releasing hormone]] | ||
Line 301: | Line 305: | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Symptoms]] | |||
[[Category:Signs and symptoms]] | [[Category:Signs and symptoms]] |
Latest revision as of 18:46, 5 June 2015
Flushing | |
ICD-10 | R23.2 |
---|---|
ICD-9 | 782.62 |
WikiDoc Resources for Flushing |
Articles |
---|
Most recent articles on Flushing |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Flushing at Clinical Trials.gov Clinical Trials on Flushing at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Flushing
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Flushing Risk calculators and risk factors for Flushing
|
Healthcare Provider Resources |
Causes & Risk Factors for Flushing |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
For a person to flush is to become markedly red in the face and often other areas of the skin, from various physiological conditions. Flushing is generally distinguished, despite a close physiological relation between them, from blushing, which is milder, generally restricted to the face or cheeks, and generally assumed to reflect embarrassment. Flushing is also a cardinal symptom of carcinoid syndrome – the syndrome that results from hormones (often serotonin or histamine) being secreted into systemic circulation.
Causes
Causes by Organ System
Causes in Alphabetical Order
Sex flush
Commonly referred to as the sex flush, vasocongestion (increased blood flow) of the skin can occur during all four phases of the human sexual response cycle. Studies show that the sex flush occurs in approximately 50-75% of females and 25% of males, yet not consistently. The sex flush tends to occur more often under warmer conditions and may not appear at all under cooler temperatures. It has also been commonly observed that the marked degree of the sex flush can predict the intensity of orgasm to follow.
During the female sex flush, pinkish spots develop under the breasts, then spread to the breasts, torso, face, hands, soles of the feet, and possibly over the entire body. Vasocongestion is also responsible for the darkening of the clitoris and the walls of the vagina during sexual arousal. During the male sex flush, the coloration of the skin develops less consistently than in the female, but typically starts with the epigastrium (upper abdomen), spreads across the chest, then continues to the neck, face, forehead, back, and sometimes, shoulders and forearms.
The sex flush typically disappears soon after orgasm occurs, but this may take up to two hours or so, and sometimes, intense sweating will occur simultaneously. The flush usually diminishes in reverse of which it appeared.